KPMG | Research | Pharma & Life Sciences

An overview of KPMG research in the Middle East in the Pharma & Life Sciences industry:

Middle East's life sciences players face high corruption risk A year on from the Covid-19 outbreak, bribery and corruption remain the top risk facing life sciences businesses in the Middle East.
06 April 2021

More KPMG news

Transforming the governance, risk and compliance (GRC) function Organizations are increasingly facing challenges that make them recognize the need for upgrading their governance, risk management and compliance (GRC) function.
06 September 2022
Payments-focused fintechs offer opportunities for banking The rise of new payment services and technology providers has been nothing short of disruptive, driven by an era of consumer centricity, and accelerated by the Covid-19 pandemic.
25 August 2022
Building a strategic procurement function in retail banking Retail banks globally are under increasing pressure to optimise their costs, across the entire value chain.
11 August 2022
Mohamad Majid (KPMG) on digital pillars of UAE's public sector The economic and social turbulence caused by the pandemic has triggered a shift in consumer behaviour and expectations.
04 August 2022

1

1 found

About Consultancy-me.com

Consultancy.org network

Consultancy.org network